Foghorn Therapeutics (FHTX) Ownership - Who owns Foghorn Therapeutics?
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FHTX showed earnings on August 05, 2025. You can read more about the earnings report here.